Television Show to Feature Skinvisible Licensee Safe4Hours(R) With Invisicare(R)

Television Show to Feature Skinvisible Licensee Safe4Hours(R) With Invisicare(R)

- Marketing Efforts Continue to Expand in Canada

LAS VEGAS, April 27 /PRNewswire-FirstCall/ -- Skinvisible, Inc. (BULLETIN BOARD: SKVI) (Website: www.skinvisible.com) and its licensee JD Nelson & Associates are pleased to announce its antimicrobial sanitizing lotion/skin protectant product Safe4Hours(R) will be featured on "Daytime," a Canadian television show produced by Rogers Television. This program is a daily magazine-style television series which features local stories and lifestyle segments. Safe4Hours will be highlighted in a gardening segment that will air at 11:00 a.m., 5:00 p.m. and 11:00 p.m. EDT today, Friday, April 27th.

(Logo: http://www.newscom.com/cgi-bin/prnh/20030416/LAW068LOGO)
(Logo: http://www.newscom.com/cgi-bin/prnh/20040503/INVISICARELOGO)

"Independent studies have verified that Safe4Hours acts as both a sanitizing lotion and a skin barrier against the absorption of noxious chemicals into the skin. This includes guarding against many of the pesticides and insecticides used in gardening today. The television feature on gardening will show how people who work outdoors can protect themselves by using Safe4Hours," said Mr. Doug Nelson, President and CEO of JD Nelson & Associates. "We are pleased with the positive feedback we have had from the television program's producers about the benefits of using Safe4Hours, and anticipate a very positive and beneficial story for consumers."

"Using Safe4Hours while gardening protects the gardener from the chemicals that lurk in the soil, plants and debris," said Mr. Terry Howlett, President and CEO of Skinvisible. "This television show is a great platform to inform people about the dangers of various chemicals and how they can protect themselves by applying Safe4Hours before they begin their outdoor projects. We are very pleased with receiving media exposure like this and know that it will assist JD Nelson & Associates in making progress in the Canadian market."

Skinvisible's business model is focused on licensing its proprietary formulations with Invisicare to pharmaceutical and cosmeceutical companies as well as assisting companies in revitalizing or enhancing their existing skin care products.

About Invisicare(R)

Skinvisible has patented its technology and trademarked its polymer delivery system Invisicare(R). Invisicare is a combination of hydrophilic and hydrophobic polymers that hold active ingredients on the skin for extended periods of time. They are non-occlusive and allow normal skin respiration and perspiration while moisturizing and protecting against exposure from a wide variety of environmental irritants. See: www.invisicare.com

About Skinvisible Pharmaceuticals, Inc.

Skinvisible Pharmaceuticals is a research-and-development company whose primary business objective is to license its proprietary formulations with Invisicare(R) to pharmaceutical and cosmeceutical companies as well as assisting companies in revitalizing or enhancing their existing skin care products. Skinvisible receives a combination of research and development fees, upfront license fees, and ongoing royalties for the life of the Invisicare patent. See www.skinvisible.com

About JD Nelson & Associates

Located in Columbus, Ohio and Toronto, CA. JD Nelson specializes in manufacturing, marketing and distributing consumer products. J. Douglas Nelson, President& CEO and Fred A. Dobson, Vice President of Sales and Marketing, together have over 46 years of marketing and distribution experience.

Forward-Looking Statements

This press release contains 'forward looking' statements within the meaning of Section 21A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, and are subject to the safe harbors created thereby. Such statements involve certain risks and uncertainties associated with an emerging company. Actual results could differ materially from those projected in the forward looking statements as a result of risk factors discussed in Skinvisible, Inc. reports on file with the U.S. Securities and Exchange Commission (including, but not limited to, a report on Form 10K for the year ending December 31, 2006.)

Corporate Contact:
Terry Howlett, President/CEO
Skinvisible Pharmaceuticals, Inc.
Phone: 702-433-7154
Email: info@skinvisible.com

Photo:

http://www.newscom.com/cgi-bin/prnh/20030416/LAW068LOGO
http://www.newscom.com/cgi-bin/prnh/20040503/INVISICARELOGO
AP Archive:

http://photoarchive.ap.org/
PRN Photo Desk, photodesk@prnewswire.com
Source: Skinvisible, Inc.

CONTACT: Terry Howlett, President/CEO of Skinvisible Pharmaceuticals,
Inc., +1-702-433-7154, info@skinvisible.com

Web site:

http://www.skinvisible.com/
http://www.invisicare.com/

-------
Profile: intent